文献速递脑血管病神经重症与神经感染

墨尔本移动卒中单元与标准救护车成本效益的因果分析

Costs and Benefits of the Melbourne Mobile Stroke Unit Compared With Standard Ambulance: Causal Analysis Using Observational Linked Data.
PubMed 文献 · Stroke · 2025-03-24

基于澳大利亚卒中临床登记库与墨尔本移动卒中单元2018年数据,采用倾向性评分匹配在目标试验框架下比较移动卒中单元与标准救护车转运患者的180天内住院费用及90-180天健康结局。移动卒中单元组住院费用更高,但无残疾 odds 和死亡率更优。

要点

  • 移动卒中单元组调整后住院费用较标准救护车组高17 949美元(95%CI 4682-31 214;P=0.01)。
  • 移动卒中单元组90-180天无残疾(mRS 0-1)的调整OR为2.11(95%CI 1.07-4.18)。
  • 移动卒中单元组90-180天死亡率的调整HR为0.53(95%CI 0.32-0.86)。

核心结论

  • 使用移动卒中单元带来重要的费用增加和结局改善,后者可能与再灌注治疗提供增加有关。

研究设计与样本

  • 因果效应估计,使用2018年澳大利亚卒中临床登记库(维多利亚)和墨尔本移动卒中单元的患者队列数据,链接救护车维多利亚和政府行政数据集,共8657例患者链接数据可用;采用倾向性评分匹配在目标试验框架内定义比较组。

主要发现

  • 目标试验样本包括移动卒中单元转运96例(干预组)和标准救护车转运198例(对照组),平均年龄76岁,男性157例(53%)。
  • 干预组接受机械取栓的比例高于对照组(40% vs 23%;P<0.001)。
  • 干预组调整后住院费用较对照组高17 949美元(95%CI 4682-31 214;P=0.01)。
  • 干预组90-180天无残疾(mRS 0-1)的调整OR为2.11(95%CI 1.07-4.18)。
  • 干预组90-180天死亡率的调整HR为0.53(95%CI 0.32-0.86)。

关键数值与推荐

  • 无残疾定义为改良Rankin量表评分0-1分。
  • 费用包括卒中后前180天的急诊科和住院费用。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Evidence of the cost implications and health outcomes associated with the use of mobile stroke units (MSU) is required to support their utilization. We aimed to evaluate the causal effect of the use of an MSU compared with a standard ambulance on hospitalization costs and 90- to 180-day health outcomes. METHODS: Causal effect estimation was performed using patient-level data from a cohort of patients with stroke in 2018 identified from the Australian Stroke Clinical Registry (Victoria) and Melbourne MSU. These data were linked to Ambulance Victoria and government-held administrative data sets. In total, linked data from 8657 patients were available. Propensity score matching was used to define comparator groups within a target trial framework. Costs included emergency department and hospital admission costs in the first 180 days after stroke. Multivariable regression analyses of the matched data were used to compare costs and outcomes (mortality and modified Rankin Scale) between MSU and standard ambulance groups. RESULTS: The target trial sample included 96 patients transported by the MSU (intervention) and 198 patients transported by standard ambulance services (control). Of these, the mean age was 76 years and 157 (53%) were men. A greater proportion of patients received mechanical thrombectomy in the intervention group than the control group (40% versus 23%; P<0.001). The adjusted hospital costs were $17 949 greater in the intervention group than the control group (95% CI, $4682-$31 214; P=0.01). Patients in intervention group doubled the odds of achieving nondisability (modified Rankin Scale scores of 0-1, adjusted odds ratio of 2.11 [95% CI, 1.07-4.18]) and halved the mortality rate (adjusted hazard ratio, 0.53 [95% CI, 0.32-0.86]) within 90 to 180 days poststroke compared with the control group. CONCLUSIONS: There are important cost implications and improved outcomes from using the MSU that are likely related to increased provision of reperfusion therapy.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Cadilhac DA, Birhanu MM, Churilov L, et al. Costs and Benefits of the Melbourne Mobile Stroke Unit Compared With Standard Ambulance: Causal Analysis Using Observational Linked Data. Stroke. 2025. PMID: 40127146. doi:10.1161/STROKEAHA.124.048403

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。